# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-26-015246
Filing Date
2026-05-06
Accepted
2026-05-06 17:00:48
Documents
67
Period of Report
2026-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | tgtx20260331_10q.htm iXBRL | 10-Q | 1655695
2 | EXHIBIT 10.1 | ex_944322.htm | EX-10.1 | 1193792
3 | EXHIBIT 31.1 | ex_926559.htm | EX-31.1 | 12340
4 | EXHIBIT 31.2 | ex_926560.htm | EX-31.2 | 12684
5 | EXHIBIT 32.1 | ex_926561.htm | EX-32.1 | 5722
6 | EXHIBIT 32.2 | ex_926562.htm | EX-32.2 | 6039
| Complete submission text file | 0001437749-26-015246.txt |  | 8570114

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA | tgtx-20260331.xsd | EX-101.SCH | 55609
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | tgtx-20260331_cal.xml | EX-101.CAL | 46486
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | tgtx-20260331_def.xml | EX-101.DEF | 396875
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | tgtx-20260331_lab.xml | EX-101.LAB | 363860
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | tgtx-20260331_pre.xml | EX-101.PRE | 427113
71 | EXTRACTED XBRL INSTANCE DOCUMENT | tgtx20260331_10q_htm.xml | XML | 937270

Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 26949519
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)